Get the Stockscreener App
71.76
0.15%
-0.11
Overview
News
Price History
Option Chain
Financials
Why CTVA Down?
Discussions
Forecast
Dividend History
Corteva Inc stock is traded at $71.76, with a volume of 2.65M.
It is down -0.15% in the last 24 hours and down -0.46% over the past month.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.
See More
Previous Close:
$71.87
Open:
$71.94
24h Volume:
2.65M
Relative Volume:
0.66
Market Cap:
$48.73B
Revenue:
$17.18B
Net Income/Loss:
$1.48B
P/E Ratio:
35.00
EPS:
2.05
Net Cash Flow:
$2.59B
1W Performance:
+1.20%
1M Performance:
-0.46%
6M Performance:
+12.20%
1Y Performance:
+36.01%
1-Day Range:
$71.60
$72.24
1-Week Range:
$70.82
$73.00
52-Week Range:
$52.59
$77.41
Corteva Inc Stock (CTVA) Company Profile
Name
Corteva Inc
Sector
Industry
Phone
(833) 267-8382
Address
9330 ZIONSVILLE ROAD, INDIANAPOLIS, DE
Compare CTVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CTVA
Corteva Inc
|
71.76 | 48.81B | 17.18B | 1.48B | 2.59B | 2.05 |
|
NTR
Nutrien Ltd
|
57.13 | 27.65B | 25.68B | 527.00M | 839.00M | 1.07 |
|
CF
Cf Industries Holdings Inc
|
85.90 | 13.81B | 6.13B | 1.34B | 1.86B | 7.59 |
|
MOS
Mosaic Company
|
32.47 | 10.19B | 11.06B | 367.80M | 212.50M | 1.16 |
|
ICL
Icl Group Ltd
|
6.18 | 7.90B | 6.84B | 407.00M | 755.00M | 0.32 |
Corteva Inc Stock (CTVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-31-25 | Upgrade | Argus | Hold → Buy |
| Mar-13-25 | Initiated | Goldman | Buy |
| Oct-23-24 | Initiated | Citigroup | Buy |
| Oct-16-24 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-07-24 | Downgrade | Argus | Buy → Hold |
| Apr-12-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Mar-01-24 | Initiated | Wolfe Research | Outperform |
| Feb-12-24 | Upgrade | Loop Capital | Hold → Buy |
| Feb-02-24 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
| Nov-27-23 | Downgrade | Berenberg | Buy → Hold |
| Nov-14-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-20-23 | Upgrade | Oppenheimer | Perform → Outperform |
| Sep-05-23 | Upgrade | UBS | Neutral → Buy |
| Jul-25-23 | Downgrade | Redburn | Buy → Neutral |
| Jun-28-23 | Initiated | Canaccord Genuity | Buy |
| May-22-23 | Upgrade | Vertical Research | Hold → Buy |
| Apr-06-23 | Initiated | Oppenheimer | Perform |
| Jan-19-23 | Initiated | Wells Fargo | Overweight |
| Jan-11-23 | Upgrade | BofA Securities | Underperform → Neutral |
| Nov-16-22 | Downgrade | UBS | Buy → Neutral |
| Nov-15-22 | Downgrade | Loop Capital | Buy → Hold |
| Aug-08-22 | Upgrade | JP Morgan | Neutral → Overweight |
| Aug-08-22 | Upgrade | ROTH Capital | Neutral → Buy |
| Jul-14-22 | Initiated | Credit Suisse | Outperform |
| Jun-01-22 | Initiated | Barclays | Overweight |
| May-06-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-14-22 | Upgrade | Loop Capital | Hold → Buy |
| Apr-14-22 | Downgrade | Vertical Research | Buy → Hold |
| Jan-31-22 | Upgrade | Redburn | Neutral → Buy |
| Oct-18-21 | Downgrade | Loop Capital | Buy → Hold |
| Oct-13-21 | Initiated | Mizuho | Buy |
| Oct-08-21 | Initiated | ROTH Capital | Buy |
| Sep-01-21 | Initiated | Berenberg | Buy |
| Aug-09-21 | Upgrade | Monness Crespi & Hardt | Sell → Neutral |
| May-10-21 | Downgrade | BofA Securities | Buy → Underperform |
| Apr-19-21 | Upgrade | Loop Capital | Hold → Buy |
| Feb-05-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Feb-05-21 | Reiterated | Monness Crespi & Hardt | Sell |
| Dec-18-20 | Downgrade | Susquehanna | Positive → Neutral |
| Dec-14-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-10-20 | Upgrade | Argus | Hold → Buy |
| Oct-19-20 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-19-20 | Downgrade | Exane BNP Paribas | Outperform → Underperform |
| Aug-11-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Aug-10-20 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-13-20 | Upgrade | BofA Securities | Underperform → Buy |
| Jun-26-20 | Initiated | Cleveland Research | Neutral |
| Jun-16-20 | Upgrade | Vertical Research | Hold → Buy |
| Jun-08-20 | Downgrade | Monness Crespi & Hardt | Neutral → Sell |
| May-11-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Apr-17-20 | Downgrade | BofA/Merrill | Buy → Neutral |
| Apr-17-20 | Upgrade | Loop Capital | Sell → Hold |
| Apr-01-20 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Mar-31-20 | Upgrade | Susquehanna | Neutral → Positive |
| Mar-26-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Mar-19-20 | Upgrade | Edward Jones | Hold → Buy |
| Mar-13-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Mar-10-20 | Upgrade | Monness Crespi & Hardt | Sell → Neutral |
View All
Corteva Inc Stock (CTVA) Latest News
Stock Analysis | Corteva OutlookMixed Signals Amid Rising Price and Analyst Optimism - AInvest
Corteva's Quarterly Earnings Preview: What You Need to Know - MSN
Corteva's 0.64% Drop and 428th Trading Rank Signal Mixed Institutional Moves and UBS Buy Upgrade - AInvest
Broad-Spectrum Insecticides - Trend Hunter
Promising Agriculture Stocks To Watch TodayAugust 12th - MarketBeat
BASF, Corteva and M.S. Technologies to bring industry-first soybean trait stack to market in Brazil - global-agriculture.com
Barclays upgrades CF Industries, Corteva on strong results, LatAm growth potential - MSN
CF Industries, Corteva upgraded at Barclays on strong results, LatAm growth potential (CF:NYSE) - Seeking Alpha
Corteva Shares Rise After Barclays Upgrade - MarketScreener
Corteva’s SWOT analysis: agricultural giant’s stock faces market headwinds By Investing.com - Investing.com Canada
Corteva’s SWOT analysis: agricultural giant’s stock faces market headwinds - Investing.com
Barclays Upgrades Corteva to Overweight From Equalweight, Adjusts Price Target to $84 From $75 - MarketScreener
Chemours, DuPont, Corteva agree to $875 million settlement over New Jersey PFAS lawsuits - Smart Water Magazine
Barclays upgrades Corteva stock rating to Overweight on strong growth outlook - Investing.com Australia
Agriculture Stocks Worth WatchingAugust 11th - MarketBeat
Wells Fargo Hikes Corteva (CTVA) Price Target Affirms ‘Overweight’ Rating - MSN
Corteva Earns Relative Strength Rating Upgrade; Hits Key Threshold - Investor's Business Daily
Corteva Shares Soar on Earnings Beat and Upgraded Guidance Despite 236th Trading Volume Ranking - AInvest
Best Agriculture Stocks To Follow NowAugust 10th - MarketBeat
Corteva beats estimates with rising demand for seed, crop protection; raises outlook - MSN
RBC Capital raises Corteva stock price target to $86 on Q2 beat - Investing.com Australia
Former Corteva leader tapped as next AgriNovus CEO - Inside INdiana Business
RBC Capital Adjusts Price Target on Corteva to $86 From $85, Maintains Outperform Rating - MarketScreener
Corteva (CTVA) Stock Surges 37.6% YOY on Strong Seed & Crop Protection GrowthNews and Statistics - IndexBox
Do Wall Street Analysts Like Corteva Stock? - Barchart.com
Investors Interested In Corteva, Inc.'s (NYSE:CTVA) Earnings - 富途牛牛
New Buy Rating for Corteva (CTVA), the Basic Materials Giant - The Globe and Mail
Corteva Gets Hold Rating from J.P. Morgan with $70 Price Target - AInvest
Corteva Reports Strong 2025 Earnings, Raises Guidance - The Globe and Mail
Top Agriculture Stocks To Keep An Eye OnAugust 7th - MarketBeat
RBC Raises Price Target on Corteva to $86 From $85, Keeps Outperform Rating - MarketScreener
Corteva, Inc. (NYSE:CTVA) Q2 2025 Earnings Call Transcript - Insider Monkey
UBS Remains a Buy on Corteva (CTVA) - The Globe and Mail
Wells Fargo Raises Price Target for Corteva (CTVA) to $83 | CTVA Stock News - GuruFocus
JPMorgan Adjusts Price Target on Corteva to $70 From $65, Maintains Neutral Rating - MarketScreener
Citigroup Adjusts Price Target on Corteva to $83 From $85, Maintains Buy Rating - MarketScreener
CTVA: Keybanc Raises Price Target for Corteva to $85.00, Maintai - GuruFocus
Corteva stock price target raised to $85 from $84 at KeyBanc - Investing.com Nigeria
Deutsche Bank Adjusts Corteva Price Target to $83 From $85, Maintains Buy Rating - MarketScreener
Oppenheimer reiterates Outperform rating on Corteva stock after strong Q2 By Investing.com - Investing.com Nigeria
Oppenheimer reiterates Outperform rating on Corteva stock after strong Q2 - Investing.com
Corteva Inc (CTVA) Q2 2025 Earnings Call Highlights: Strong EBIT - GuruFocus
Research Alert: CFRA Upgrades Opinion On Shares Of Corteva, Inc. To Buy From Hold - 富途牛牛
Corteva Tolvera % JL Farmakis IncAd from 2025-08-08 - AgUpdate
Decoding Corteva Inc (CTVA): A Strategic SWOT Insight - GuruFocus
Corteva's 58.8% Trading Volume Surge Ranks 212th as Strong Q2 Earnings Drive Mixed Investor Sentiment - AInvest
Corteva (CTVA) Gets Boost from Oppenheimer Analyst Kristen Owen with New Buy Recommendation - AInvest
Corteva Earnings Call Highlights Robust Growth Amid Challenges - TipRanks
Corteva, Inc. (CTVA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - MSN
Corteva, Inc. SEC 10-Q Report - TradingView
Corteva Earnings: Raising Fair Value to $75 From $70 on Strong First-Half Results - Morningstar
Corteva Inc Stock (CTVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):